Management of Diarrhea in Young Children in Sub-Saharan Africa: Adherence to World Health Organization Recommendations During the Global Enteric Multisite Study (2007-2011) and the Vaccine Impact of Diarrhea in Africa (VIDA) Study (2015-2018).
Africa
IMCI guidelines
WHO
diarrhea management
Journal
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213
Informations de publication
Date de publication:
19 04 2023
19 04 2023
Historique:
medline:
21
4
2023
pubmed:
19
4
2023
entrez:
19
04
2023
Statut:
ppublish
Résumé
Reducing diarrhea-related morbidity and mortality is a global priority, particularly in low-resource settings. We assessed adherence to diarrhea case management indicators in the Global Enteric Multisite Study (GEMS) and Vaccine Impact of Diarrhea in Africa (VIDA) study. GEMS (2007-2010) and VIDA (2015-2018) were age-stratified case-control studies of moderate-to-severe diarrhea (MSD) in children aged <5 years. In this case-only analysis, we included children enrolled in The Gambia, Kenya, and Mali. A case with no dehydration received adherent care at home if they were offered more than usual fluids and at least the same as usual to eat. Children with diarrhea and some dehydration are to receive oral rehydration salts (ORS) in the facility. The recommendation for severe dehydration is to receive ORS and intravenous fluids in the facility. Adherent care in the facility included a zinc prescription independent of dehydration severity. For home-based management of children with MSD and no signs of dehydration, 16.6% in GEMS and 15.6% in VIDA were adherent to guidelines. Adherence to guidelines in the facility was likewise low during GEMS (some dehydration, 18.5%; severe dehydration, 5.5%). The adherence to facility-based rehydration and zinc guidelines improved during VIDA to 37.9% of those with some dehydration and 8.0% of children with severe dehydration. At research sites in The Gambia, Kenya, and Mali, suboptimal adherence to diarrhea case management guidelines for children aged <5 years was observed. Opportunities exist for improvement in case management for children with diarrhea in low-resource settings.
Sections du résumé
BACKGROUND
Reducing diarrhea-related morbidity and mortality is a global priority, particularly in low-resource settings. We assessed adherence to diarrhea case management indicators in the Global Enteric Multisite Study (GEMS) and Vaccine Impact of Diarrhea in Africa (VIDA) study.
METHODS
GEMS (2007-2010) and VIDA (2015-2018) were age-stratified case-control studies of moderate-to-severe diarrhea (MSD) in children aged <5 years. In this case-only analysis, we included children enrolled in The Gambia, Kenya, and Mali. A case with no dehydration received adherent care at home if they were offered more than usual fluids and at least the same as usual to eat. Children with diarrhea and some dehydration are to receive oral rehydration salts (ORS) in the facility. The recommendation for severe dehydration is to receive ORS and intravenous fluids in the facility. Adherent care in the facility included a zinc prescription independent of dehydration severity.
RESULTS
For home-based management of children with MSD and no signs of dehydration, 16.6% in GEMS and 15.6% in VIDA were adherent to guidelines. Adherence to guidelines in the facility was likewise low during GEMS (some dehydration, 18.5%; severe dehydration, 5.5%). The adherence to facility-based rehydration and zinc guidelines improved during VIDA to 37.9% of those with some dehydration and 8.0% of children with severe dehydration.
CONCLUSIONS
At research sites in The Gambia, Kenya, and Mali, suboptimal adherence to diarrhea case management guidelines for children aged <5 years was observed. Opportunities exist for improvement in case management for children with diarrhea in low-resource settings.
Identifiants
pubmed: 37074440
pii: 7130321
doi: 10.1093/cid/ciac926
pmc: PMC10116557
doi:
Substances chimiques
Vaccines
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
S23-S31Subventions
Organisme : NIAID NIH HHS
ID : T32 AI007524
Pays : United States
Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Déclaration de conflit d'intérêts
Potential conflicts of interest. K. L. K. reports consultation fees and travel support from PATH and the University of Washington related to diarrheal diseases and grant support to her institution from the National Institute of Allergy and Infections Diseases, Institut Pasteur, and the Bill & Melinda Gates Foundation. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Références
Clin Infect Dis. 2012 Dec;55 Suppl 4:S246-53
pubmed: 23169937
BMC Pediatr. 2017 Mar 21;17(1):83
pubmed: 28320354
BMJ Open. 2018 Jul 30;8(7):e019079
pubmed: 30061428
Lancet. 2013 Apr 20;381(9875):1417-1429
pubmed: 23582723
Clin Infect Dis. 2023 Apr 19;76(Supplement_1):S5-S11
pubmed: 37074428
Gastroenterology. 2010 Oct;139(4):1156-64
pubmed: 20638937
Lancet. 2013 Jul 20;382(9888):209-22
pubmed: 23680352
Lancet Glob Health. 2018 Mar;6(3):e255-e269
pubmed: 29433665
Lancet Glob Health. 2019 May;7(5):e568-e584
pubmed: 31000128
J Glob Health. 2019 Jun;9(1):010101
pubmed: 30701067
Soc Sci Med. 2007 Feb;64(3):701-12
pubmed: 17097788
Soc Sci Med. 2013 Jun;86:66-78
pubmed: 23608095
PLoS One. 2014 Apr 09;9(4):e93427
pubmed: 24718483
PLoS One. 2021 Apr 22;16(4):e0249638
pubmed: 33886584
Lancet Infect Dis. 2020 Jan;20(1):37-59
pubmed: 31678029
J Glob Health. 2019 Dec;9(2):020801
pubmed: 31673345
J Diarrhoeal Dis Res. 1989 Sep-Dec;7(3-4):70-6
pubmed: 2632638
BMC Res Notes. 2012 Oct 24;5:576
pubmed: 23095352
Clin Infect Dis. 2012 Dec;55 Suppl 4:S232-45
pubmed: 23169936
BMC Med. 2020 Dec 21;18(1):405
pubmed: 33342436
Bull World Health Organ. 2007 Jan;85(1):42-8
pubmed: 17242757
Lancet Glob Health. 2020 Aug;8(8):e1038-e1060
pubmed: 32710861